Showing results (1241-1250 of 1,350) with videos related to
Sort By:
Pageof 135
Journal of Proteome Research|August 10, 2025
Assessing Long-Term Stored Tissues for Multi-Omics Data Quality and Proteogenomics SuitabilityKyu Jin Song, Minsuh Kim, Yong Jin Heo, et al.Journal of Bone Oncology|May 24, 2021
Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastasesHaeyoung Kim, Hongryull Pyo, Hee Chul Park, et al.Oncotarget|January 13, 2016
Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)Ji Yun Lee, Xu Qing, Wei Xiumin, et al.Nature Cell Biology|September 11, 2023
Widespread 8-oxoguanine modifications of miRNA seeds differentially regulate redox-dependent cancer developmentSangkyeong Eom, Jongjin Peak, Jongyeun Park, et al.European Journal of Cancer (Oxford, England : 1990)|October 27, 2023
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)Se Hyun Kim, Seock-Ah Im, Koung Jin Suh, et al.Arthritis and Rheumatism|March 2, 2011
Association of a functional IRF7 variant with systemic lupus erythematosusQiong Fu, Jian Zhao, Xiaoxia Qian, et al.Oncotarget|December 7, 2017
Thio-barbiturate-derived compounds are novel antioxidants to prevent LPS-induced inflammation in the liverKyoung Mi Moon, Bonggi Lee, Ji Won Jeong, et al.Plos One|April 20, 2012
An essential regulatory role of downstream of kinase-1 in the ovalbumin-induced murine model of asthmaChang-Min Lee, In Duk Jung, Kyung Tae Noh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinum-based chemotherapy in non small-cell lung cancerJoon Oh Park, Sang-We Kim, Jin Seok Ahn, et al.Modern Rheumatology|December 11, 2013
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and JapanSoo-Kyung Cho, Ryoko Sakai, Toshihiro Nanki, et al.Pageof 135